|Bid||1.7600 x N/A|
|Ask||1.7800 x N/A|
|Day's Range||1.7500 - 1.8500|
|52 Week Range||1.7500 - 4.1000|
|Beta (5Y Monthly)||1.53|
|PE Ratio (TTM)||23.60|
|Earnings Date||Apr. 14, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||3.24|
KELOWNA, BC, Sept. 18, 2020 /CNW/ - The Valens Company Inc.
KELOWNA, BC, Aug. 19, 2020 /CNW/ - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company" or "The Valens Company"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced that it has received its Cannabis Research Licence under Health Canada's Cannabis Act and Cannabis Regulations through its wholly-owned subsidiary, Valens Agritech Ltd.
KELOWNA, BC, Aug. 13, 2020 /CNW/ - The Valens Company Inc.